Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin and Metformin Combination Therapy in Type 2 Diabetes
CTR20140696Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started Oct 2014; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20140696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140696.